The Effect of Silica Surface Area on Microparticle Retention Systems

Retention of fines and fillers has always been a concern in the paper industry. There has been many different types of retention aids in the past, but they lack performance under the vigorous conditions in today\u27s paper mills. High shear forces associated with high speed paper of recycled materials into the mill brought along with it high fines content and a lot of anionic trash which readily reacts with cationic polymers. Consequently, the dosage must be increased which can lead to poor formation and increased chemical cost. A new retention aid was needed to combat these problems. Microparticle retention systems were developed by a group of papermakers, scientist, and process control experts in the late 1970\u27s. A dramatic improvement in retention and drainage was achieved, which allowed higher filler loading, increased machine speeds, and better formation. To this date, continuing research is being done on the improvement of microparticle retention aids as well as developing new retention aids. This paper deals with microparticle retention systems in a different way. Normally, the dosage of microparticle, anionic silica in this research, to the system is on a weight basis, i.e., pounds of microparticle per ton of paper. In this study, silica dosage will be done on a surface area basis. Silica particles have a very high specific surface area, which can range anywhere from around 500m2/g to 1200m2/g. Using this information and the typical dosage rate on a weight basis, a surface area dosage can be calculated. For example, 600m2/g X 1.0 lb./ton = 272,155m2/ton and 1200m2/g X 0.5lb./ton X 272,155m2/ton . Both give the same surface area dosage, but different only half of the weight basis dosage is needed for the high surface area silica. Therefore, the objective of this thesis is to test the hypothesis that equivalent retention will be obtained when equal surface area dosage is applied to the system. A two level, three variable factorial design was used to test the effects of surface area of microparticle, surface area dosage, and polymer dosage. Two different furnishes were used, a fine paper grade and a wood containing grade. Both grades are similar to those found in industry. All retention studies were carried out using a Britt Dynamic Drainage Jar. Percent fines and ash retention was measured. The results for the fine paper furnish showed no conclusive trends other than an effect of polymer dosage on fines retention. The variability in the system was extremely high. The wood containing furnish, however showed several promising results. Again, the polymer dosage was found to have a large effect on the system. There was an interaction between surface area dosage and polymer dosage. At low polymer dosages, the surface area dosage had an effect on retention, but at high polymer dosage, there was not an improved retention response as the surface area dosage increased. Finally, the wood containing furnish followed the hypothesis that equivalent retention will be obtained at equal surface area dosage. Many chemical suppliers pride themselves on the high surface area of their microparticle and the improved performance it offers. The results of this thesis show that this may not be exactly true. The dosage needed to get the same retention with a high surface area microparticle may be less, but not necessarily improved performance. If retention could be measured as a function of surface area added to the system per ton of paper, a mill could determine what is the most economical microparticle to use. For example, a supplier could supply a low surface area microparticle at a very low price, while the another supplier is offering a high surface area microparticle at an extremely high price. The mill would have to use a lot more of the low surface area microparticle to get the retention they want, but it sill may be more economical

Photometry using the Infrared Array Camera on the Spitzer Space Telescope

We present several corrections for point source photometry to be applied to data from the Infrared Array Camera (IRAC) on the Spitzer Space Telescope. These corrections are necessary because of characteristics of the IRAC arrays and optics and the way the instrument is calibrated in-flight. When these corrections are applied, it is possible to achieve a ~2% relative photometric accuracy for sources of adequate signal to noise in an IRAC image.Comment: 16 pages, 13 figures. Accepted for publication in the Publications of the Astronomical Society of the Pacifi

Family of Hermitian Low-Momentum Nucleon Interactions with Phase Shift Equivalence

Using a Schmidt orthogonalization transformation, a family of Hermitian low-momentum NN interactions is derived from the non-Hermitian Lee-Suzuki (LS) low-momentum NN interaction. As special cases, our transformation reproduces the Hermitian interactions for Okubo and Andreozzi. Aside from their common preservation of the deuteron binding energy, these Hermitian interactions are shown to be phase shift equivalent, all preserving the empirical phase shifts up to decimation scale Lambda. Employing a solvable matrix model, the Hermitian interactions given by different orthogonalization transformations are studied; the interactions can be very different from each other particularly when there is a strong intruder state influence. However, because the parent LS low-momentum NN interaction is only slightly non-Hermitian, the Hermitian low-momentum nucleon interactions given by our transformations, including the Okubo and Andreozzi ones, are all rather similar to each other. Shell model matrix elements given by the LS and several Hermitian low-momentum interactions are compared.Comment: 10 pages, 7 figure

Self-aware Computing in the Angstrom Processor

Addressing the challenges of extreme scale computing requires holistic design of new programming models and systems that support those models. This paper discusses the Angstrom processor, which is designed to support a new Self-aware Computing (SEEC) model. In SEEC, applications explicitly state goals, while other systems components provide actions that the SEEC runtime system can use to meet those goals. Angstrom supports this model by exposing sensors and adaptations that traditionally would be managed independently by hardware. This exposure allows SEEC to coordinate hardware actions with actions specified by other parts of the system, and allows the SEEC runtime system to meet application goals while reducing costs (e.g., power consumption).United States. Defense Advanced Research Projects Agency. The Ubiquitous High Performance Computing Progra

A decade of stability for wMel Wolbachia in natural Aedes aegypti populations

Mosquitoes carrying Wolbachia endosymbionts are being released in many countries for arbovirus control. The wMel strain of Wolbachia blocks Aedes-borne virus transmission and can spread throughout mosquito populations by inducing cytoplasmic incompatibility. Aedes aegypti mosquitoes carrying wMel were first released into the field in Cairns, Australia, over a decade ago, and with wider releases have resulted in the near elimination of local dengue transmission. The long-term stability of Wolbachia effects is critical for ongoing disease suppression, requiring tracking of phenotypic and genomic changes in Wolbachia infections following releases. We used a combination of field surveys, phenotypic assessments, and Wolbachia genome sequencing to show that wMel has remained stable in its effects for up to a decade in Australian Ae. aegypti populations. Phenotypic comparisons of wMel-infected and uninfected mosquitoes from near-field and long-term laboratory populations suggest limited changes in the effects of wMel on mosquito fitness. Treating mosquitoes with antibiotics used to cure the wMel infection had limited effects on fitness in the next generation, supporting the use of tetracycline for generating uninfected mosquitoes without off-target effects. wMel has a temporally stable within-host density and continues to induce complete cytoplasmic incompatibility. A comparison of wMel genomes from pre-release (2010) and nine years post-release (2020) populations show few genomic differences and little divergence between release locations, consistent with the lack of phenotypic changes. These results indicate that releases of Wolbachia-infected mosquitoes for population replacement are likely to be effective for many years, but ongoing monitoring remains important to track potential evolutionary changes

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials

Remdesivir (RDV) is a broad-spectrum nucleotide analog prodrug approved for the treatment of COVID-19 in hospitalized and non-hospitalized patients with clinical benefit demonstrated in multiple Phase 3 trials. Here we present SARS-CoV-2 resistance analyses from the Phase 3 SIMPLE clinical studies evaluating RDV in hospitalized participants with severe or moderate COVID-19 disease. The severe and moderate studies enrolled participants with radiologic evidence of pneumonia and a room-air oxygen saturation of ≤94% or >94%, respectively. Virology sample collection was optional in the study protocols. Sequencing and related viral load data were obtained retrospectively from participants at a subset of study sites with local sequencing capabilities (10 of 183 sites) at timepoints with detectable viral load. Among participants with both baseline and post-baseline sequencing data treated with RDV, emergent Nsp12 substitutions were observed in 4 of 19 (21%) participants in the severe study and none of the 2 participants in the moderate study. The following 5 substitutions emerged: T76I, A526V, A554V, E665K, and C697F. The substitutions T76I, A526V, A554V, and C697F had an EC50 fold change of ≤1.5 relative to the wildtype reference using a SARS-CoV-2 subgenomic replicon system, indicating no significant change in the susceptibility to RDV. The phenotyping of E665K could not be determined due to a lack of replication. These data reveal no evidence of relevant resistance emergence and further confirm the established efficacy profile of RDV with a high resistance barrier in COVID-19 patients

The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) - a multicentre parallel-group randomised trial to compare early computerised tomography coronary angiography versus standard care in patients presenting with suspected or confirmed acute coronary syndrome: study protocol for a randomised controlled trial.

BACKGROUND: Emergency department attendances with chest pain requiring assessment for acute coronary syndrome (ACS) are a major global health issue. Standard assessment includes history, examination, electrocardiogram (ECG) and serial troponin testing. Computerised tomography coronary angiography (CTCA) enables additional anatomical assessment of patients for coronary artery disease (CAD) but has only been studied in very low-risk patients. This trial aims to investigate the effect of early CTCA upon interventions, event rates and health care costs in patients with suspected/confirmed ACS who are at intermediate risk. METHODS/DESIGN: Participants will be recruited in about 35 tertiary and district general hospitals in the UK. Patients ≥18 years old with symptoms with suspected/confirmed ACS with at least one of the following will be included: (1) ECG abnormalities, e.g. ST-segment depression >0.5 mm; (2) history of ischaemic heart disease; (3) troponin elevation above the 99(th) centile of the normal reference range or increase in high-sensitivity troponin meeting European Society of Cardiology criteria for 'rule-in' of myocardial infarction (MI). The early use of ≥64-slice CTCA as part of routine assessment will be compared to standard care. The primary endpoint will be 1-year all-cause death or recurrent type 1 or type 4b MI at 1 year, measured as the time to such event. A number of secondary clinical, process and safety endpoints will be collected and analysed. Cost effectiveness will be estimated in terms of the lifetime incremental cost per quality-adjusted life year gained. We plan to recruit 2424 (2500 with ~3% drop-out) evaluable patients (1212 per arm) to have 90% power to detect a 20% versus 15% difference in 1-year death or recurrent type 1 MI or type 4b MI, two-sided p < 0.05. Analysis will be on an intention-to-treat basis. The relationship between intervention and the primary outcome will be analysed using Cox proportional hazard regression adjusted for study site (used to stratify the randomisation), age, baseline Global Registry of Acute Coronary Events score, previous CAD and baseline troponin level. The results will be expressed as a hazard ratio with the corresponding 95% confidence intervals and p value. DISCUSSION: The Rapid Assessment of Potential Ischaemic Heart Disease with CTCA (RAPID-CTCA) trial will recruit 2500 participants across about 35 hospital sites. It will be the first study to investigate the role of CTCA in the early assessment of patients with suspected or confirmed ACS who are at intermediate risk and including patients who have raised troponin measurements during initial assessment. TRIAL REGISTRATION: ISRCTN19102565 . Registered on 3 October 2014. ClinicalTrials.gov: NCT02284191

IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.

BACKGROUND: Results of a previous study with human leukocyte antigen (HLA)-identical siblings showed individual and synergistic associations of single nucleotide polymorphisms in the promoter region of the recipient's IL10 gene and the donor's IL10 receptor beta (IL-10RB) gene with development of grades III-IV acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation. METHODS: In this study of 936 patients who had unrelated donors, genotypes of single nucleotide polymorphisms in the IL10 gene and the IL-10RB gene were evaluated as correlates with outcomes after transplantation. RESULTS: We found no statistically significant associations of polymorphisms at positions -3575, -2763, -1082, and -592 of the IL10 gene or codon 238 of the IL10RB gene with severe acute GVHD, extensive chronic GVHD or nonrelapse mortality after hematopoietic cell transplantation. Among HLA-matched unrelated pairs, the patient's IL10/-592 genotype and donor's IL10RB/c238 genotype showed trends suggesting individual and combined associations with grades III-IV acute GVHD similar to those observed among patients with HLA-identical sibling donors. CONCLUSIONS: Although genetic variation in IL10 pathway affects risk of acute GVHD and non-relapse mortality in HLA-identical sibling transplants, the current results indicate that genetic variation in the IL10 pathway does not significant affect these outcomes in unrelated donor transplants suggesting that the strength of the alloimmune response in the latter exceeds the anti-inflammatory activity of IL10

Dynamic Chromatin Localization of Sirt6 Shapes Stress- and Aging-Related Transcriptional Networks

The sirtuin Sirt6 is a NAD-dependent histone deacetylase that is implicated in gene regulation and lifespan control. Sirt6 can interact with the stress-responsive transcription factor NF-κB and regulate some NF-κB target genes, but the full scope of Sirt6 target genes as well as dynamics of Sirt6 occupancy on chromatin are not known. Here we map Sirt6 occupancy on mouse promoters genome-wide and show that Sirt6 occupancy is highly dynamic in response to TNF-α. More than half of Sirt6 target genes are only revealed upon stress-signaling. The majority of genes bound by NF-κB subunit RelA recruit Sirt6, and dynamic Sirt6 relocalization is largely driven in a RelA-dependent manner. Integrative analysis with global gene expression patterns in wild-type, Sirt6−/−, and double Sirt6−/− RelA−/− cells reveals the epistatic relationships between Sirt6 and RelA in shaping diverse temporal patterns of gene expression. Genes under the direct joint control of Sirt6 and RelA include several with prominent roles in cell senescence and organismal aging. These data suggest dynamic chromatin relocalization of Sirt6 as a key output of NF-κB signaling in stress response and aging